ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
SAB Biotherapeutics Inc

SAB Biotherapeutics Inc (SABSW)

0.069
-0.004
( -5.48% )
Updated: 08:35:02

Income Statement

Balance Sheet

Cash Flow

Quarter End Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 3.59M2.16M581k86k1.27M305k945k263k
Operating Income -7.81M-7.86M-7.4M-6.48M-5.32M-18.87M-11.39M-10.2M
Pre Tax Income -7.08M-7.85M-7.35M-6.88M-5.1M-22.86M-5.03M-7.34M
Net Income -7.08M-7.88M-7.35M-6.88M-5.1M-22.86M-5.03M-7.34M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -7.81M-7.83M-7.4M-6.48M-5.23M-18.54M-10.92M-9.83M
EBITDA -6.92M-6.96M-6.51M-5.61M-4.36M-17.95M-9.43M-9.17M
Year End December 30 2023 2020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 060.88M23.9M2.24M
Operating Income -9k-13.39M-28.92M-38.08M
Pre Tax Income -9k-17.15M-18.72M-42.19M
Net Income -9k-17.15M-18.74M-42.19M
Preferred Dividends 0000
Basic Earnings Per Share (EPS) -0.003-0.394-0.436-0.806
EBIT -9k-13.39M-28.88M-37.64M
EBITDA -9k-11.91M-25.75M-34.42M

Your Recent History

Delayed Upgrade Clock